ARCHIVES

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

M. D. Anderson Buys Record System For In-Patient Services From Atlanta Firm.

May 4, 2001

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978

DRCCA To Get Name Change, Three Major Program Areas

August 27, 1982